Hurwitz SJ - Search Results

1

Pharmacodynamics of DT-IgG, a dual-targeting antibody against VEGF-EGFR, in tumor xenografted mice.

Hurwitz SJ, Zhang H, Yun S, Batuwangala TD, Steward M, Holmes SD, Rycroft D, Pan L, Tighiouart M, Shin HJ, Koenig L, Wang Y, Chen ZG, Shin DM. Hurwitz SJ, et al. Cancer Chemother Pharmacol. 2012 Mar;69(3):577-90. doi: 10.1007/s00280-011-1713-x. Epub 2011 Sep 13. Cancer Chemother Pharmacol. 2012. PMID: 21913035

2

Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.

Saba NF, Hurwitz SJ, Kono SA, Yang CS, Zhao Y, Chen Z, Sica G, Müller S, Moreno-Williams R, Lewis M, Grist W, Chen AY, Moore CE, Owonikoko TK, Ramalingam S, Beitler JJ, Nannapaneni S, Shin HJ, Grandis JR, Khuri FR, Chen ZG, Shin DM. Saba NF, et al. Among authors: hurwitz sj. Cancer Prev Res (Phila). 2014 Mar;7(3):283-91. doi: 10.1158/1940-6207.CAPR-13-0215. Epub 2013 Oct 3. Cancer Prev Res (Phila). 2014. PMID: 24085777 Free PMC article. Clinical Trial.

3

Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancer.

Klass CM, Choe MS, Hurwitz SJ, Tighiouart M, Zhang X, Chen ZG, Shin DM. Klass CM, et al. Among authors: hurwitz sj. Head Neck. 2009 Oct;31(10):1263-73. doi: 10.1002/hed.21103. Head Neck. 2009. PMID: 19399750 Free PMC article.

4

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck.

Saba NF, Hurwitz SJ, Magliocca K, Kim S, Owonikoko TK, Harvey D, Ramalingam SS, Chen Z, Rogerio J, Mendel J, Kono SA, Lewis C, Chen AY, Higgins K, El-Deiry M, Wadsworth T, Beitler JJ, Shin DM, Sun SY, Khuri FR. Saba NF, et al. Among authors: hurwitz sj. Cancer. 2014 Dec 15;120(24):3940-51. doi: 10.1002/cncr.28965. Epub 2014 Aug 7. Cancer. 2014. PMID: 25103371 Free article. Clinical Trial.

5

Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.

Anisuzzaman AS, Haque A, Rahman MA, Wang D, Fuchs JR, Hurwitz S, Liu Y, Sica G, Khuri FR, Chen ZG, Shin DM, Amin AR. Anisuzzaman AS, et al. Cancer Prev Res (Phila). 2016 Jan;9(1):63-73. doi: 10.1158/1940-6207.CAPR-15-0240. Epub 2015 Oct 28. Cancer Prev Res (Phila). 2016. PMID: 26511491 Free PMC article.

6

Systemic Delivery of Bc12-Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth.

Rahman MA, Wang P, Zhao Z, Wang D, Nannapaneni S, Zhang C, Chen Z, Griffith CC, Hurwitz SJ, Chen ZG, Ke Y, Shin DM. Rahman MA, et al. Among authors: hurwitz sj. Angew Chem Int Ed Engl. 2017 Dec 11;56(50):16023-16027. doi: 10.1002/anie.201709485. Epub 2017 Nov 15. Angew Chem Int Ed Engl. 2017. PMID: 29076273 Free PMC article.

7

Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells.

Wang P, Rahman MA, Zhao Z, Weiss K, Zhang C, Chen Z, Hurwitz SJ, Chen ZG, Shin DM, Ke Y. Wang P, et al. Among authors: hurwitz sj. J Am Chem Soc. 2018 Feb 21;140(7):2478-2484. doi: 10.1021/jacs.7b09024. Epub 2018 Feb 12. J Am Chem Soc. 2018. PMID: 29406750 Free PMC article.

8

Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.

Chen H, Pai SB, Hurwitz SJ, Chu CK, Glazkova Y, McClure HM, Feitelson M, Schinazi RF. Chen H, et al. Among authors: hurwitz sj. Antimicrob Agents Chemother. 2003 Jun;47(6):1922-8. doi: 10.1128/AAC.47.6.1922-1928.2003. Antimicrob Agents Chemother. 2003. PMID: 12760868 Free PMC article.

9

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study.

Hurwitz SJ, Tao S, Gavegnano C, Jiang Y, Tressler RL, Tsibris A, Del Rio C, Overton ET, Lederman MM, Kantor A, Moser C, Kohler JJ, Lennox J, Marconi VC, Flexner CW, Schinazi RF. Hurwitz SJ, et al. J Clin Pharmacol. 2021 Dec;61(12):1555-1566. doi: 10.1002/jcph.1930. Epub 2021 Jul 23. J Clin Pharmacol. 2021. PMID: 34169526 Free PMC article. Clinical Trial.

10

Viral pharmacodynamic model for (-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine (emtricitabine) in chronically infected woodchucks.

Hurwitz SJ, Tennant BC, Korba BE, Liberman I, Gerin JL, Schinazi RF. Hurwitz SJ, et al. Antivir Chem Chemother. 2002 May;13(3):165-76. doi: 10.1177/095632020201300303. Antivir Chem Chemother. 2002. PMID: 12448689 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page